A(4-24)(F23A)H2 [417]



A(4-24)(F23A)H2


SMILES CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)O)[C@@H](C)O)C(C)C
InChIKey JPICFXXNKSFHNE-FHWINVSDSA-N
Sequence SALANKCCHVGCTKRSLARAC
HELM PEPTIDE1{S.A.L.A.N.K.C.C.H.V.G.C.T.K.R.S.L.A.R.A.C}$$$$

Chemical Properties

Hydrogen bond acceptors 35
Hydrogen bond donors 37
Rotatable bonds 73
Log P -14.156
Molecular weight (Da) 2191.1
Stereochemistry info partial

Database connections



Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

A(4-24)(F23A)H2


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.